Jue Wang

Nov 12, 2024 | bmccancer.biomedcentral.com | Yinggang Xu |Lifeng Huang |Jue Wang |Jinzhi He |Ye Wang |Weiwei Zhang | +7 more

Based on previous studies, the incidence of grade 3–4 neutropenia for the control group was assumed to be 40%, and we hypothesized that the incidence in the experimental group would be halved to 20%. Using a two-sided significance level (α) of 0.05 and a power of 80%, the calculated sample size for each group was 79 patients. Given the short duration of the study, we anticipate a low rate of loss to follow-up.

Oct 20, 2024 | mdpi.com | Jue Wang

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Oct 11, 2024 | mdpi.com | Yiyang Liu |Jue Wang

1. IntroductionThe urgency to address climate change has prompted a global surge in the adoption of carbon reduction measures. As the leading emitter of carbon dioxide, China has proactively engaged with international demands through its “dual-carbon” strategy, targeting a peak in carbon emissions by 2030 and carbon neutrality by 2060.

Sep 19, 2024 | mdpi.com | Jue Wang |Xiao Wang |Feng Sun |Xinyu Li

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Sep 11, 2024 | mdpi.com | Jue Wang

This is an early access version, the complete PDF, HTML, and XML versions will be available soon.